CTRI/2019/06/019755尚未招募3 期
RANDOMIZED CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF VIDANG TAILANASYA AND GOGHRITA NASYA IN THE MANAGEMENT OF ARDHAVBHEDAK
Pallavi Pandurang Vyavahare1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2019年6月25日最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 72
- 试验地点
- 1
- 主要终点
- Subjective criteria ( by using Grades and Visual analogues Pain Scale)
研究概览
简要总结
- Screening of patient of Ardhavbhedak will be done using a purposive sampling method. Followed by random sampling by lottery method, who meets the inclusion criteria, till the desired sample size is achieved.
- 72 Patient of Ardhavbhedak will be purposively selected in OPD/IPD basis irrespective of of gender, economic status, religion, occupation.
- 72 Patient will be allocated randomly into two groups-by Lottery methods.
- Group A (Trial Group): 36 patients will be treated with Vidang Taila Nasya for 7 days Dose: 2 drops (1/2 ml) Group B (Control Group):36 patients will be treated with Goghrita NasyaFor 7 days Dose: 2 drops (1/2 ml).
- Criteria for assessment -
| subjective criteria will assess will be assessed with help of scoring pattern, Vas scale |
Objective criteria will be assess with the help of Grading Pattern
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 60.00 Year(s)（—）
- 性别
- All
入选标准
- •Patient suffering from symptoms of Ardhavbhedak i.e. Ardha Manya, Bhru, Shankha, Karna, Akshi, Lalat Ativedanam and Shastra Arni Nibha and Bhrama Patient between age group 20 to 60 yrs.
- •Patient of either gender.
排除标准
- •Patients suffering from sinusitis systemic disorders like hypertension and dibetes Secondary headache caused by meningitis tumor encephalitis and refractive errors Pregnancy and lactation.
结局指标
主要结局
Subjective criteria ( by using Grades and Visual analogues Pain Scale)
时间窗: 21 days
Bhrama (giddiness)
时间窗: 21 days
Shatra Arni Nibha (Throbbing pain)
时间窗: 21 days
Unilateral severe pain affecting neck brow ear and orbital area forehead region
时间窗: 21 days
Objective criteria (by Gradation)
时间窗: 21 days
1 severity of headache
时间窗: 21 days
2 frequency of headache
时间窗: 21 days
3 duration of headache
时间窗: 21 days
4 Episode of Vomiting
时间窗: 21 days
4 Duration of Aura
时间窗: 21 days
次要结局
- Study the concept of Ardhavbhedak and Migraine in details(Study the Nasya Kriyakalpa and its uses indications contra indications complications)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
PET/MRI in Patients With Suspected Prostate CancerProstate CancerNCT02659527Medical University of Vienna220
Unknown
2 期
A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCCHead and Neck NeoplasmsNCT03678649Zhejiang Cancer Hospital180
已完成
不适用
Supervised Exercise for Post-surgery Colorectal Cancer PatientsColorectal NeoplasmsColorectal CancerNCT05090215University of Nottingham21
已完成
不适用
Study Looking at the Effect of Silverlon on Post Operative Wound InfectionsInfectionsSurgeryNCT01143883Jorge Marcet110
已完成
2 期
Clinical Evaluation of Leech Therapy in the Treatment of Knee OsteoarthritisKnee OsteoarthritisNCT02612974Hamdard University60